adical surgical resection is the main treatment for advanced and recurrent rectal cancer. 1 Prospective studies have shown that more extensive surgery, such as extralevator abdominoperineal excision, results in higher radicality and improved survival compared to conventional abdominoperineal resection. [2][3][4] If multiple compartments are involved, curative treatment can be achieved by performing pelvic exenteration. 5 Neoadjuvant chemotherapy and/or radiotherapy has been shown to increase radical resection rates, decrease local recurrence rates, and increase cancer-specific survival. 6 Dead pelvic space and radiotherapy require functional reconstruction. 7 Using well-vascularized, nonirradiated tissue can reduce wound complications. 8 Perineal wound dehiscence and surgical-site infections negatively impact on the